Tilactase is a beta-D-galactosidase use to treat lactose intolerance. Tilactase is a beta-D-galactosidase obtained from Aspergillus oryzae.
- Mechanism
- Curator reviewed · 2 references
Lactose is the primary disaccharide found in dairy products. Tilactase is a type of lactase which is the enzyme that is in charge of the breakdown of lactose to glucose and galactose which can be used by the body. Basically, tilactase acts by replacing the missing lactase in the body and allows avoidance of the reach of lactose to the small intestine and the normal bacteria and thus, preventing the symptoms of the lactose intolerance. Once tilactase has metabolized the lactose, the metabolism products are reabsorbed by the normal process of digestion.
- Primary indication
- Tilactase is indicated for the symptomatic treatment of lactose intolerance in infants and older patients requiring a parenteral nutrition or fluid diet.Curator reviewed · 1 structured indication
- Formula / weight
- 102000.0 Da
- First approval
- Canada, 1999
- Also known as
- beta-D-Galactosidase · beta-Galactosidase · Lactase
- Code names
- S 2107 · SL 396
Resolves to
What you can answer from here — as of September 14, 2026
Which other approved drugs treat the same conditions as Tilactase, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account